Drug Shortage Report for SANDOZ IRBESARTAN HCT

Last updated on 2020-07-20 History
Report ID 80200
Drug Identification Number 02337444
Brand name SANDOZ IRBESARTAN HCT
Common or Proper name IRBESARTAN HCT
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 25MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2018-11-05
Estimated end date 2020-07-10
Actual end date 2020-07-03
Shortage status Resolved
Updated date 2020-07-20
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v26 2020-07-20 French Compare
v25 2020-07-20 English Compare
v24 2020-06-08 French Compare
v23 2020-06-08 English Compare
v22 2020-05-11 French Compare
v21 2020-05-11 English Compare
v20 2020-05-04 French Compare
v19 2020-05-04 English Compare
v18 2020-04-06 French Compare
v17 2020-04-06 English Compare
v16 2020-03-30 French Compare
v15 2020-03-30 English Compare
v14 2020-02-15 French Compare
v13 2020-02-15 English Compare
v12 2020-01-08 French Compare
v11 2020-01-08 English Compare
v10 2019-12-10 French Compare
v9 2019-12-10 English Compare
v8 2019-11-18 French Compare
v7 2019-11-18 English Compare

Showing 1 to 20 of 26